JPS5655369A - Pyridinemethanol derivative - Google Patents
Pyridinemethanol derivativeInfo
- Publication number
- JPS5655369A JPS5655369A JP13230779A JP13230779A JPS5655369A JP S5655369 A JPS5655369 A JP S5655369A JP 13230779 A JP13230779 A JP 13230779A JP 13230779 A JP13230779 A JP 13230779A JP S5655369 A JPS5655369 A JP S5655369A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- compound
- day
- sympathtic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
NEW MATERIAL:A compound of formula I (R is alkyl, alkenyl, alkynyl, cycloalkyl, etc.; R<1> and R<2> are H or alkyl; R<3> is 1-20C alkyl, aralkyl, aryloxyalkyl, etc.; R<2> ?and R<3> together may form a heterocyclic ring with the adjacent N; X is -0-, -S-, ?-SO-, etc.; m is O or 1) or its salt. EXAMPLE:1-(2-Isopropylthio-3-pyridyl)-2-n-octylaminopropanol.1/2 oxalate. USE:Pharmaceuticals having brain blood stream increasing, vasodilating, antithrombic, cholesterol level lowering, hypotensive, sympathtic beta-receptor blocking actions. Does: 10-1,500mg/kg wt./day by oral administration. One to several times a day. PROCESS:The compound of formula I is prepared by reducing an aminoketone compound of formula II (R<4> is R<2> or an amino-protecting group eliminable by hydrolysis or hydrogenation decomposition).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13230779A JPS5655369A (en) | 1979-10-12 | 1979-10-12 | Pyridinemethanol derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13230779A JPS5655369A (en) | 1979-10-12 | 1979-10-12 | Pyridinemethanol derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5655369A true JPS5655369A (en) | 1981-05-15 |
JPS6130668B2 JPS6130668B2 (en) | 1986-07-15 |
Family
ID=15078238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13230779A Granted JPS5655369A (en) | 1979-10-12 | 1979-10-12 | Pyridinemethanol derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5655369A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62263155A (en) * | 1986-05-06 | 1987-11-16 | バイエル・アクチエンゲゼルシヤフト | Use of heteroarylethylamine for animal growth promotion, heteroarylethylamine and manufacture |
US5714506A (en) * | 1995-10-24 | 1998-02-03 | Merck & Co., Inc. | Selective β3 agonists for the treatment of diabetes and obesity |
AU2018332501B2 (en) * | 2017-09-13 | 2023-09-21 | Atrogi Ab | Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia |
-
1979
- 1979-10-12 JP JP13230779A patent/JPS5655369A/en active Granted
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62263155A (en) * | 1986-05-06 | 1987-11-16 | バイエル・アクチエンゲゼルシヤフト | Use of heteroarylethylamine for animal growth promotion, heteroarylethylamine and manufacture |
US5714506A (en) * | 1995-10-24 | 1998-02-03 | Merck & Co., Inc. | Selective β3 agonists for the treatment of diabetes and obesity |
AU2018332501B2 (en) * | 2017-09-13 | 2023-09-21 | Atrogi Ab | Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia |
US12036210B2 (en) | 2017-09-13 | 2024-07-16 | Atrogi Ab | Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia |
Also Published As
Publication number | Publication date |
---|---|
JPS6130668B2 (en) | 1986-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE892129L (en) | Chemical compounds | |
ZA8410021B (en) | 11beta-arylestradienes,their production,and pharmaceutical preparations containing same | |
NO170280C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULPHAMATE DERIVATIVES | |
ATE79376T1 (en) | DITHIOACETAL COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ES8304563A1 (en) | Isoquinoline derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
NO882334L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKANSULPHONANILIDE DERIVATIVES. | |
DE3477488D1 (en) | Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives | |
ATE12641T1 (en) | AZEPININDOLS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ES8701189A1 (en) | S-(carbamoyl-phenylselenyl) derivatives of mercaptans, process for their preparation and pharmaceutical preparations containing them. | |
JPS5655369A (en) | Pyridinemethanol derivative | |
FR2378026A1 (en) | MEDICINAL PRODUCTS CONTAINING DERIVATIVES OF HYDROXYMETHYL-2-AMINO-2'-DIPHENYL SULFIDE | |
DK511383A (en) | PROCEDURE FOR THE PREPARATION OF PIPERIDINE INDION DERIVATIVES PROTECTING THE HEART MUSCULAR WITH ANTIARYTHMIC ACTIVITY | |
ES8303397A1 (en) | 1(4-Quinolyl)ethanol or propanol derivatives, pharmaceutical compositions containing them and processes for their preparation. | |
FR2434150A1 (en) | HYDROXAMIC ACID DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT | |
DE3880564D1 (en) | MEDICINES FOR TREATING HEART INSUFFICIENCY. | |
EP0299076A4 (en) | 5-hydroxyindole-3-carboxamide compound and medicinal use thereof | |
GR3001468T3 (en) | 5-aminoalkyl-beta-carboline derivatives, their preparation and their use as medicaments | |
ES8401062A1 (en) | 1-Furyl-3,4-dihydroisoquinolines, process for their preparation, their use and medicines containing them. | |
SE9203824L (en) | BENSOFURANYLIMIDAZOLE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THERAPEUTIC COMPOSITIONS CONTAINING THEM | |
JPS57131777A (en) | Preparation of piperazine derivative | |
DK644487D0 (en) | PHARMACEUTICAL PREPARATION CONTAINING A 2-OXO-IMIDAZOLIDE COMPOUND | |
FR2386524A1 (en) | AMINO-4 CHLORO-5 METHOXY-2 N- (N-ETHYL METHYL-2 PYRROLIDINO) BENZENESULFONAMIDE, PROCESS OF PREPARATION AND MEDICINAL PRODUCTS CONTAINING IT | |
ES8104265A1 (en) | Benzenesulfinamides, a process for the preparation thereof and medicaments containing them. | |
ES8704947A1 (en) | Imidazopyridayine derivatives having antiviral activity | |
GB1471237A (en) | Basically substituted benzenesulphonamides and process for preparing them |